Effect of calibration methods on the accuracy of angiographic measurements during transcatheter procedures in dogs          下载免费PDF全文

Lauren E. Markovic  Brian A. Scansen 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2018,32(3):956-961

  相似文献   

Development and implementation of a novel immune thrombocytopenia bleeding score for dogs          下载免费PDF全文

Kelly M. Makielski  Marjory B. Brooks  Chong Wang  Jonah N. Cullen  Annette M. O'Connor  Dana N. LeVine 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2018,32(3):1041-1050

  相似文献   

Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease          下载免费PDF全文

Marco Baron Toaldo  Giovanni Romito  Carlo Guglielmini  Alessia Diana  Nazzareno G. Pelle  Barbara Contiero  Mario Cipone 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2018,32(3):914-921

  相似文献   

Comparative,multidimensional imaging of patent ductus arteriosus and a proposed update to the morphology classification system for dogs          下载免费PDF全文

Kelley R. Doocy  Ashley B. Saunders  Sonya G. Gordon  Nicholas Jeffery 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2018,32(2):648-657

  相似文献   

Evaluation of individual low‐dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs          下载免费PDF全文

Michael Bennaim  Robert E. Shiel  Christopher Forde  Carmel T. Mooney 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2018,32(3):967-977

  相似文献   

烯丙孕素口服液调控母猪同期发情的研究进展   总被引：1，自引：0，他引：1  

冯言言  徐恩民  郑莉  林红  孔梅  吴连勇 《中国兽药杂志》2018,52(4):66-72

烯丙孕素口服液在国外已被广泛用于母猪同期发情,给药期间可抑制母猪发情,停止给药后重新释放天然激素,母猪会重返发情,以达到同步发情。详细阐述了烯丙孕素口服液的作用机制、药代动力学、临床应用、残留以及毒性,以期为其研究与开发提供一定的参考。烯丙孕素口服液在治疗性成熟母猪同期发情上有较好的应用前景。  相似文献   

Primary tonsillar mast cell tumour in a dog          下载免费PDF全文

CC Shekell  MJ Thomson  RI Miller  JT Mackie 《Australian veterinary journal》2018,96(5):184-187

  相似文献   

Effect of dasatinib in a xenograft mouse model of canine histiocytic sarcoma and in vitro expression status of its potential target EPHA2          下载免费PDF全文

K. Ito  R. Miyamoto  H. Tani  S. Kurita  M. Kobayashi  K. Tamura  M. Bonkobara 《Journal of veterinary pharmacology and therapeutics》2018,41(1):e45-e48

Canine histiocytic sarcoma (HS) is an aggressive and highly metastatic tumor. Previously, the kinase inhibitor dasatinib was shown to have potent growth inhibitory activity against HS cells in vitro, possibly via targeting the EPHA2 receptor. Here, the in vivo effect of dasatinib in HS cells was investigated using a xenograft mouse model. Moreover, the expression status of EPHA2 was examined in six HS cell lines, ranging from insensitive to highly sensitive to dasatinib. In the HS xenograft mouse model, dasatinib significantly suppressed tumor growth, as illustrated by a decrease in mitotic and Ki67 indices and an increase in apoptotic index in tumor tissues. On Western blot analysis, EPHA2 was only weakly detected in all HS cell lines, regardless of sensitivity to dasatinib. Dasatinib likely results in the inhibition of xenograft tumor growth via a mechanism other than targeting EPHA2. The findings of this study suggest that dasatinib is a targeted therapy drug worthy of further exploration for the treatment of canine HS.  相似文献   

Effects of p.o. administered xylitol in cats          下载免费PDF全文

Á. Jerzsele  Z. Karancsi  E. Pászti‐Gere  Á. Sterczer  A. Bersényi  K. Fodor  D. Szabó  P. Vajdovich 《Journal of veterinary pharmacology and therapeutics》2018,41(3):409-414

Xylitol is commonly used as sugar substitute in households. While it has numerous beneficial effects on human health, it is highly toxic to dogs. The goal of this study was to examine whether xylitol has similar deleterious effects, such as hypoglycaemia and acute hepatic failure, on cats. Our research included six healthy middle‐aged cats. Xylitol was dissolved in deionized water and administered p.o. at three doses (100, 500 and 1,000 mg/kg body weight). These dosages have been considered toxic and can cause liver failure or even death in dogs. After every xylitol administration, the basic health status and the blood glucose of cats were observed regularly. Additionally, prior to and 6, 24 and 72 hr after xylitol administration, blood samples were taken to check complete blood count, clinical biochemical parameters and enzymes such as ALT, ALKP, GGT, GLDH, bile acids, BUN, creatinine, phosphate, total protein, albumin, sodium and potassium. There were no significant changes (p > .05) in any of the haematological or biochemical parameters. Blood glucose concentrations did not show any significant alterations, except at 1,000 mg/kg dose, where a mild but significant increase was observed, but it was in physiological range. Based on our results, xylitol did not induce toxic effects on cats.  相似文献   

Repeat patient testing shows promise as a quality control method for veterinary hematology testing          下载免费PDF全文

Bente Flatland  Kathleen P. Freeman 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》2018,47(2):252-266

Background

Repeat patient testing‐based quality control (RPT‐QC) is a potential method for veterinary laboratories (eg, that have a limited budget for quality commercial control material [QCM] or that wish to use material with a species‐specific matrix).

Objectives

To determine whether total error (TE_a), probability of error detection (Ped), and probability of false rejection (Pfr) similar to that achievable with QC materials can be controlled using RPT‐QC

Methods

Control limits (WBC, RBC, HGB, HCT, MCV, and PLT) for the Advia 120 (n = 23) and scil Vet ABC (n = 22) were calculated using data from normal canine specimens from a routine caseload. Specimens were measured at accession and again after 24 hours. Control limits were validated using 23 additional canine specimens tested similarly. Achievable TEa, Ped, and Pfr were investigated using the Westgard EZRules3 and compared to those achievable with commercial QCM.

Results

Theoretical performance of RPT‐QC and commercial QCM‐QC are similar for 1‐3s with both n = 1 and 1‐3s with n = 2 for all measurands and both instruments. Achievable TE_a values for RPT‐QC were close to ASVCP recommendations for most measurands; exceptions were PLT (both instruments) and WBC (scil Vet ABC).

Conclusions

Repeat patient testing‐based quality control advantages include a species‐specific matrix, low‐cost, and absence of QC material deterioration over time (since a fresh specimen is used each day). A potential disadvantage is daily access to normal canine specimens. A challenge is determining control limits, which has a subjective element. Further study is needed to confirm actual RPT‐QC performance and to determine if RPT‐QC with abnormal patient specimens is feasible.  相似文献